桃仁红花煎联合康复训练治疗缺血性脑卒中患者的疗效及对GDF-15、SIRT1和MMP-9水平的影响OACSTPCD
Efficacy of Taoren Honghua Decoction Combined with Rehabilitation Training in the Treatment of Patients with Ischemic Stroke and Its Effects on GDF-15,SIRT1 and MMP-9 Levels
目的:探讨桃仁红花煎联合康复训练治疗缺血性脑卒中患者的疗效及对血清生长分化因子-15(GDF-15)、沉默信息调节因子 1(SIRT1)和基质金属蛋白酶-9(MMP-9)水平的影响.方法:选取 2022 年 2 月至 2023 年 7 月于定州市人民医院治疗的缺血性脑卒中患者 84 例,采用随机数字表法分为联合组与训练组,各 42 例.训练组患者采用基础治疗+康复训练,联合组患者在训练组的基础上加用桃仁红花煎治疗.观察联合组与训练组患者的临床疗效…查看全部>>
OBJECTIVE:To probe into the efficacy of Taoren Honghua decoction combined with rehabilitation training in the treatment of patients with ischemic stroke and its effects on growth differentiation factor-15(GDF-15),silent information regulatory factor 1(SIRT1)and matrix metalloproteinase-9(MMP-9)levels.METHODS:A total of 84 patients with ischemic stroke admitted into Dingzhou People's Hospital from Feb.2022 to Jul.2023 were extracted to be divided into the com…查看全部>>
李男;朱玉晓;贾建萍;杨培
定州市人民医院康复医学科,河北 定州 073000廊坊市中医医院针灸脑病科,河北 廊坊 065000河北省新河县人民医院神内放射科,河北 邢台 055650定州市人民医院康复医学科,河北 定州 073000
药学
桃仁红花煎康复训练缺血性脑卒中生长分化因子-15基质金属蛋白酶-9沉默信息调节因子1
Taoren Honghua decoctionRehabilitation trainingIschemic strokeGrowth differentiation factor-15Matrix metalloproteinase-9Silent information regulatory factor 1
《中国医院用药评价与分析》 2024 (9)
1050-1053,4
河北省中医药管理局2023年度中医药类科学研究课题计划(No.2023298)
评论